BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Total Revenue

Revenue analysis for IPA.

Quarterly Revenue

$4.09M
↓ 33.5% YoY

As of Jan 2026

Annual Revenue (TTM)

$18.40M
↓ 23.34% YoY

Trailing 12 months ending Jan 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin